ASM/weight
1 paper2 findings
- Humans1
Associations
2Metabolic dysfunction- and alcohol-associated liver disease
downin humans1RR 0.5
1 study
Metabolic dysfunction- and alcohol-associated liver disease
downin humans1RR 0.5
ASM/weight lowers the risk of metabolic dysfunction- and alcohol-associated liver disease in humans (RR 0.50, 95% CI 0.27-0.93).
“There were negative associations of MetALD with ASM/height2 and ASM/weight (0.49, 0.26-0.94; 0.50, 0.27-0.93)”
Humans4.3 yearsn = 1,964
ADA Scientific Sessions 2025 abstract13 Jun 2025
More on Metabolic dysfunction- and alcohol-associated liver disease
Metabolic dysfunction-associated steatotic liver disease
downin humans1RR 0.59
1 study
Metabolic dysfunction-associated steatotic liver disease
downin humans1RR 0.59
ASM/weight lowers the risk of metabolic dysfunction-associated steatotic liver disease in humans (RR 0.59, 95% CI 0.46-0.76).
“Higher ASM/weight and ASM/BMI were associated with lower MASLD risk (risk ratio [RR] per standard deviation [SD] 0.59, 95% CI 0.46-0.76; 0.51, 0.40-0.64).”
Humans4.3 yearsn = 1,964
ADA Scientific Sessions 2025 abstract13 Jun 2025
More on Metabolic dysfunction-associated steatotic liver disease
Latest
1 in 12 monthsFrontiers in Aging
Preliminary assessment of sarcopenic obesity risk after sleeve gastrectomy using dual-modality imaging: a six-month MRI and DXA pilot study in women
Non-randomised trial in 11 peopleSarcopenic obesity
ADA Scientific Sessions 2025 Abstract
Effects of Skeletal Muscle Mass and Its Associated Mediators on the Development of Steatotic Liver Disease—Findings from a Prospective Cohort Study in China
Cohort study of 1,964 peopleSteatotic liver disease